Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024
IVIEW Therapeutics Inc. announces to present the positive topline result in the Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis in the upcoming 2024 ARVO (The Association for Research in Vision and Ophthalmology) national meeting in Seattle, WA. The Presentation... - February 28, 2024 - iView Therapeutics Inc.
GENINVO, a Leading Provider of Life Science Product and Business Solutions Announced the Offering of Its On-Demand Service/Tool: ApoGI™
ApoGI™ is an integrated, one stop automation platform that leverages Artificial Intelligence and Machine Learning algorithms to focus on standards and metadata driven generation of artifacts. The Primary objective of this platform is to help SMEs (Subject matter experts) focus on curating... - February 15, 2024 - GenInvo, Inc.
Biomed Industries Inc. Seeks Collaboration for New Diabetes/Obesity Drug
Biomed Industries, Inc. (Biomed) announced today that it has developed a promising obesity drug, NA-921, which is poised for Phase 2/3 clinical trials. NA-921 is a small molecule drug available in oral formulation. The Company is in discussions with potential partners for collaboration on a Phase... - February 04, 2024 - Biomed Industries Inc.
Patient Experience and Satisfaction with Electronic Consent, Onboarding, and Diaries in Clinical Trials Report
New Market Research Shows Different Patient Preferences for Electronic Diaries - January 31, 2024 - Life Science Strategy Group, LLC
New Sustainable Lyophilization Technology Uses Supercritical CO2
The Thar group of companies have been using CO2 for extraction, purification, particle design and encapsulation for many years but recent developments point to a need for sustainable methods for drying APIs, intermediates, excipients and biologics at relatively low temperatures. 'Big Pharma' has depended on Thar for SFC tools in drug discovery but lyophilization will likely be used in manufacturing too. - January 28, 2024 - Thar Process, LLC
Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues
Creative Diagnostics has announced the launch of its new Robenidine Test Reagents for the detection of robenidine residues. - January 26, 2024 - Creative Diagnostics
HearYou.org and Mark Cuban Cost Plus Drug Company: Pioneering Affordable Mental Health Care
Leaders in Mental Health and Pharmaceutical Pricing Forge Path for Accessible Treatment - January 25, 2024 - Wellness Together
David P. Summers, Ph.D., FACA Honored as a Professional of the Year for 2023 by Strathmore’s Who’s Who Worldwide
Dr. David P. Summers of Montgomery, Texas has been recognized as a Professional of the Year for 2023 by Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of Biomedical Engineering/Pharmacology. About Dr. David P. Summers, PH.D,... - January 11, 2024 - Strathmore Worldwide
Bench International Enters Into Ground Breaking Strategic Alliance with Ashton Tweed
First of Its Kind Alliance Extends Mutual Service Offerings to Better Serve Clients - January 03, 2024 - Bench International
Empowering Data Privacy: GENINVO Offers Anonymization as a Service
GENINVO, a leading provider of life science product and business solutions announced the offering of its on-demand service Anonymization as a Service. GENINVO a trailblazer in data privacy solutions, is excited to introduce its ground-breaking offering, Anonymization as a Service. With data... - December 14, 2023 - GenInvo, Inc.
FF Biotherapeutics Announces Search for Angel Investment to Revolutionize Immunotherapy and Vaccine Development
FF Biotherapeutics, a pioneering biotech startup at the forefront of immunotherapy and vaccine development, today announced its active pursuit of Angel investment. This critical funding round aims to propel the development of its groundbreaking Synthetic Standardized Convalescent Plasma (SSCP) and... - November 29, 2023 - FF Biotherapeutics
SciCord Informatics Platform R3.0 Boron Release
SciCord is proud to announce a new release of its Cloud-based Laboratory Informatics Platform. - November 22, 2023 - SciCord
Huntington Study Group® Holds 30th Annual Meeting
The Huntington Study Group® (HSG®), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently held its 30th annual meeting, HSG 2023, November 2-4 in Phoenix, AZ. Hundreds of scientists, industry partners, HSG research... - November 21, 2023 - Huntington Study Group
Novugen Pharma (USA) LLC Launches ANDA Approved Midodrine 2.5mg, 5mg & 10mg
Novugen Pharma (USA) LLC has launched Midodrine 2.5mg, 5mg and 10mg in the U.S. upon the approval from ANDA by FDA. Novugen’s Midodrine will be manufactured in Malaysia by Novugen Pharma Sdn. Bhd. Midodrine is indicated for the treatment of symptomatic orthostatic hypotension, a condition defined as a sudden drop in blood pressure upon standing from a sitting or supine position. - November 07, 2023 - Novugen
Microvascular Therapeutics Receives $3.98M Award from Department of Defense for Its Cardiovascular Product
Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, AZ, was recently awarded a $3.98M FY22 Technology/Therapeutic Development – Funding Level 2 grant from the Congressionally Directed Medical Research Programs (CDMRP). Emmanuelle Meuillet, Chief... - October 18, 2023 - Microvascular Therapeutics, Inc.
Huntington Study Group® Observational Pilot Study Shows HSG’s myHDstory® Platform Reaches the Unreachable
The Huntington Study Group® (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc. (HSGCR), a world leader in conducting clinical trials for Huntington’s disease (HD), today announces that the pilot observational study on their innovative online direct-to-patient... - October 16, 2023 - Huntington Study Group
Creative Diagnostics Launches Checkerboard Assay Services
Creative Diagnostics has recently announced the launch of its new Checkerboard Assay services to support researchers. - October 15, 2023 - Creative Diagnostics
Alevea Mental Health Advocates for Psychedelic Therapy, Citing MAPS' Latest Research and Its Own Success with Ketamine Treatment
Alevea Mental Health fully endorses psychedelic therapy as an effective mental health treatment, following the recent publication of MAPS' Phase 3 study on MDMA-assisted therapy for PTSD. Alevea has already reported significant success in alleviating symptoms of anxiety, depression, and PTSD through its own Ketamine treatment programs. CEO Topher Bradshaw expressed astonishment at the remarkable patient improvements, particularly when other treatments had failed. - September 20, 2023 - Alevea Mental Health
DEA and Telemedicine: East Coast Telepsychiatry's Push for Modernized Rules
On September 12 and 13, 2023, the DEA discussed telemedicine regulations. East Coast Telepsychiatry's representatives, Pierre Montalvo and Dan Golden, attended in Arlington, VA. Mr. Golden emphasized the importance of telemedicine in prescribing controlled substances. The 2008 Ryan Haight Act's regulations are outdated, prompting the DEA to reconsider after receiving a record of over 38,000 complaints. - September 18, 2023 - East Coast Telepsychiatry
Gotham Biotech's New Histoplasma Urinary Antigen EIA Kit Now Available for Purchase
The Gotham Biotech Histoplasma Urinary Antigen EIA is an enzyme immunoassay (EIA) intended to qualitatively detect the presence of Histoplasma capsulatum galactomannan antigen in human urine specimens. This kit, when used in conjunction with other diagnostic measures, can be used as an aid in the diagnosis of histoplasmosis. - September 08, 2023 - Gotham Biotech
Gateway Recruiting Launches Their First Life Sciences Marketing Salary Survey
Gateway Recruiting has launched a salary survey for Marketing professionals in Medical Device, Biotech, and Pharma sectors. Running from August 21st to October 6th, 2023, the survey aims to provide insights into compensation trends, internal equity, and industry changes, with participants receiving a complimentary report. - August 25, 2023 - Gateway Recruiting
Altucell Advances First-Ever Regulatory-Approved Human Islet Cell Encapsulation Therapy for Type 1 Diabetes
Altucell CEO Gary Harlem says this treatment could potentially eradicate the need for insulin and immunosuppressants. - August 22, 2023 - AltuCell Therapeutics
AMCI Now with Safe Torque Off (STO)
Advanced Micro Controls Inc. (AMCI), E2 products now with Safe Torque Off (STO)! Our space saving motion solutions are now available with built-in safety functionality. - August 21, 2023 - AMCI
Neurobit Launches Neurobit HUB: A Comprehensive Tool for Streamlining Sleep and Population Health Research
Neurobit announces the launch of Neurobit HUB, a groundbreaking AI-driven tool for sleep and population health research. Integrating 40 sleep biomarkers, 20 health AI modules, and clinically validated devices, it's designed to streamline clinical trials, foster collaboration, and accelerate discoveries. A revolutionary step in sleep science. Learn more at https://www.neurobit.com/research/hub - August 14, 2023 - neurobit
Nordic Cold Chain Solutions Expands Testing and Lab Capabilities with New State-of-the-Art Chamber
Nordic Cold Chain Solutions, a leading provider of temperature-controlled packaging solutions, is excited to announce the expansion of its testing and lab capabilities with the addition of a new testing chamber. This equipment further strengthens Nordic Cold Chain Solutions' commitment to delivering top-quality products and ensuring the utmost reliability and performance for its customers. - August 10, 2023 - Nordic Cold Chain Solutions
Dr. Pam Gumbs Honored as a VIP Member by P.O.W.E.R. (Professional Organization of Women of Excellence Recognized)
Dr. Pam Gumbs of Berkeley, California has been honored as a VIP Member by P.O.WE.R. (Professional Organization of Women of Excellence Recognized) for her outstanding contributions and achievements in the pharmaceutical field. About Dr. Pam Gumbs Dr. Pam Gumbs is the owner and CEO of United... - August 09, 2023 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized
Addressing the Impact of Heat on Medications During Transportation: PMC Pharmacy Advocates for Private Hand Delivery to Safeguard Patient Safety
A key issue arising from this summer's record breaking heat waves is the effect on mail order medication that sits in hot mailboxes or porches. There is a solution and it's important for our most vulnerable residents, often dealing with chronic conditions, to follow the directions on their medication that they should be stored at 59 to 77 degrees °F in a cool, dry place. The solution is a local independent pharmacy. - July 22, 2023 - PMC Pharmacy
AMCI Sales Rep Territory Expands West
AMCI is expanding their coverage from coast to coast in order to manage the demand within the automation industry. Contour Motion, Inc. is now representing Advanced Micro Controls Inc. (AMCI) In California, Nevada, Arizona, and New Mexico. - July 20, 2023 - AMCI
Husson University’s July Summer Camps Offer Students the Opportunity to Explore Healthcare and Pharmacy
Two different science-oriented camps being held at Husson University this July will give high school students the opportunity to explore careers in pharmacy and healthcare. Sponsored by Husson University’s College of Health and Pharmacy, these camps are an outstanding way for students to... - July 13, 2023 - Husson University
PharmStars Announces Spring 2023 Accelerator Graduates: 13 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces that 13 startups have graduated from its Spring 2023 program focused on “Innovations in Women’s Health or Health Equity.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week program. PharmaU culminated with a Showcase Event, held in Boston in May, that brought together the participating startups and PharmStars’ innovation-minded pharma members. - June 20, 2023 - PharmStars
U.S. Congressman Mike Lawler Speaks to Pharmaceutical Execs Regarding Disparities in Marketing to Underserved Ethnic Minorities
United States Congressman Michael Lawler delivered a message at the MMM Media Convene Conference: Multicultural Marketing: Pharma’s New Frontier. The Congressman cited the disparities in messaging to ethnic minorities by the pharmaceutical industry and called out government agencies for lack of oversight. - June 08, 2023 - Emerging Networks
PharmStars Announces “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface” Theme for its Fall 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is accepting applications for its Fall 2023 cohort around the theme “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.” The cohort is open to startups with digital health solutions that pharma can use to innovate therapeutic supply chain management, medication delivery, or the patient-drug experience for small molecules, biologics, or advanced therapies. Applications are due July 10, 2023. - June 06, 2023 - PharmStars
GenInvo Part of PHUSE US Connect & Informa Connect Clinical Data Disclosure, Transparency & Plain Language Summaries Event - 2023
GENINVO was a part of 2 recent global events for the life science industry. The first was "PHUSE US Connect 2023" which was held in Renaissance Orlando at SeaWorld Florida on 5th – 8th March 2023 and the second event, Informa Connect Clinical Data Disclosure, Transparency &... - June 05, 2023 - GenInvo, Inc.
Opening New Frontiers in Oral Care and the Cannabinoid Market
A groundbreaking patent has been unveiled, presenting a revolutionary method for the prevention and treatment of dental pulp-associated diseases using a cannabinoid-based composition. This patent offers pharmaceutical companies a unique opportunity to enter the rapidly growing cannabinoid market while addressing critical dental care needs. - June 04, 2023 - CannIBite
New Research Benchmarks Biopharmaceutical Perceptions of Global CRO Thought Leadership
Landmark Research Analyzes Perspectives of US and EU Biopharma C-Suite, Clinical Operations and Medical/Regulatory Affairs Professionals on Global CRO Thought Leadership. - June 01, 2023 - Life Science Strategy Group, LLC
AcceleDev Celebrates Its 20 Year Anniversary
AcceleDev Chemical LLC, a leading strategic supplier of Pharmaceutical process custom synthesis services, is proud to celebrate its 20th Anniversary this month. Since its inception in 2003, AcceleDev has remained focused on helping pharmaceutical and biotech companies deliver life-saving... - May 25, 2023 - AcceleDev Chemical LLC
Creative Diagnostics Announces Calprotectin Reagents for Inflammatory Disease Research
Creative Diagnostics, a leading global supplier of raw materials, antibodies, and reagents to the biotechnology industry, is proud to announce the launch of its new line of Calprotectin Reagents for the study of inflammation disease. Calprotectin is an abundant inflammatory marker in the... - May 20, 2023 - Creative Diagnostics
PharmStars Announces Spring 2023 Startup Showcase Event Underway
PharmStars, the pharma-focused accelerator for digital health startups, announces that its fourth Showcase Event begins May 16, 2023. The Showcase is the culmination of the Spring 2023 10-week accelerator program. At the Showcase, each startup in the fourth cohort makes a formal presentation to and meets individually with PharmStars’ pharma members. The theme of the Spring 2023 program is digital innovations in women’s health or health equity. - May 16, 2023 - PharmStars
Parvus Therapeutics Announces a Publication Describing the Cellular Origin of Treg Cells Generated Endogenously by Navacim Therapy
Parvus Therapeutics announced today the publication of data showing that peptide-MHC class II-coated nanoparticles (Navacims) operate by triggering the expansion of cognate T follicular helper (TFH) cells. - May 09, 2023 - Parvus Therapeutics U.S., Inc.
Micro Merchant Systems Wins Stevie Award® for Outstanding Product Innovation in the 2023 American Business Awards®
Micro Merchant Systems, Inc., developer of the PrimeRx™ pharmacy technology management system, has been recognized for “Achievement in Product Innovation” and awarded a bronze Stevie® Award in the 2023 American Business Awards® competition. - May 04, 2023 - Micro Merchant Systems
Liberum Independent Medical Education Announces Management Buyout
Liberum Independent Medical Education, provider of independent medical education (IME) to healthcare professionals worldwide, has announced a management buyout (MBO) from its original owner, OHC London Holdings Ltd. The MBO was led by the company's Managing Director, Celeste Kolanko who has taken ownership of the company which now operates as Liberum IME BV, and Liberum Independent Medical Education Ltd. - April 29, 2023 - Liberum Independent Medical Education Ltd
Creative Diagnostics Introduces New Low Endotoxin Antibodies for Researchers
Creative Diagnostics recently introduced a new line of low endotoxin antibodies to biopharmaceutical research laboratories. - April 29, 2023 - Creative Diagnostics
NanoCellect Biomedical Announces New Distribution Partnerships in Asia and Europe
NanoCellect Biomedical, the leading provider of microfluidic flow cytometry platforms, has announced new distributor partnerships in Asia and Europe to expand its global reach and provide greater accessibility to its innovative technologies. - April 26, 2023 - NanoCellect Biomedical
Mokena Family Donates Emergency Response Kits to All Lincoln-Way Area Schools
Who: Brandon and Jennifer Wilson, of Mokena, are donating one LiveSafer or LiveSafer XL modular public access first aid cabinet to each school building in the Lincoln-Way High School District and all of its feeder elementary schools in Mokena, New Lenox, Manhattan, Frankfort, and Frankfort Square,... - April 05, 2023 - Illinois Supply Company
HSG and HD-CAB Collaborate to Provide Global Patient Advisory Board
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), recently collaborated with Huntington’s Disease – Community Advisory Board (HD-CAB) to provide a... - March 30, 2023 - Huntington Study Group
Popit and MediService Join Forces to Transform How Swiss Patients Take Medications
Popit, a pioneer in improving medication adherence, and MediService, a Swiss specialty pharmacy, are joining forces to revolutionize medication adherence for patients in Switzerland. In this collaboration, the Swiss pharmacy with a focus on caring for people with chronic and rare disease, will offer Popit to their patients taking anticoagulants to further improve adherence and patient outcome. - March 30, 2023 - Popit Ltd.
New Research on Decentralized Clinical Trial (DCT) Strategies to Boost Patient Diversity
Current and Future Clinical Trial Participants Link Enhanced Diversity and Inclusion of Underrepresented Patient Populations to DCT - March 29, 2023 - Life Science Strategy Group, LLC
Unlock Hidden Pharmacy Fax Numbers with ScriptFax
ScriptFax™ offers one of the most complete databases of pharmacy fax numbers for use across the healthcare industry and, in particular, for the delivery of prescriptions and refill requests. Developed by CarePrecise LLC, a U.S. healthcare provider data company, ScriptFax uses advanced data mining to acquire hard-to-find fax for more than 47,000 chain pharmacy locations, as well as 42,000+ drug stores, clinical, and compounding pharmacies nationwide. - March 28, 2023 - CarePrecise LLC
New Research Identifies Latest Clinical Development and CRO Outsourcing Trends in China
Groundbreaking Research Explores the Chinese Innovative Biopharmaceutical Clinical Development Market, CRO Outsourcing and Future Growth with Over 100 Chinese Biopharma Professionals - March 15, 2023 - Life Science Strategy Group, LLC
GENINVO Launches Its Latest Offering – Datalution
GenInvo, a leading provider of life science product and business solutions announced the launch of its new, on-demand service: Datalution. GenInvo has recognized various challenges the pharmaceutical industry faces, especially in generating data for clinical trials. The need of clinical data to... - March 11, 2023 - GenInvo, Inc.